Suppr超能文献

一款用于增加小儿实体器官移植人群免疫接种率的智能手机应用程序:开发与初步可用性研究。

A Smartphone App to Increase Immunizations in the Pediatric Solid Organ Transplant Population: Development and Initial Usability Study.

作者信息

Feldman Amy G, Moore Susan, Bull Sheana, Morris Megan A, Wilson Kumanan, Bell Cameron, Collins Margaret M, Denize Kathryn M, Kempe Allison

机构信息

Adult and Child Consortium for Health Outcomes Research and Delivery Science, Aurora, CO, United States.

University of Colorado School of Medicine, Aurora, CO, United States.

出版信息

JMIR Form Res. 2022 Jan 13;6(1):e32273. doi: 10.2196/32273.

Abstract

BACKGROUND

Vaccine-preventable infections result in significant morbidity, mortality, and costs in pediatric transplant recipients. However, at the time of transplant, less than 20% of children are up-to-date for age-appropriate immunizations that could prevent these diseases. Smartphone apps have the potential to increase immunization rates through their ability to provide vaccine education, send vaccine reminders, and facilitate communication between parents and a multidisciplinary medical group.

OBJECTIVE

The aim of this study was to describe the development of a smartphone app, Immunize PediatricTransplant, to promote pretransplant immunization and to report on app functionality and usability when applied to the target population.

METHODS

We used a mixed methods study design guided by the Mobile Health Agile Development and Evaluation Lifecycle. We first completed a formative research including semistructured interviews with transplant stakeholders (12 primary care physicians, 40 parents or guardians of transplant recipients, 11 transplant nurse coordinators, and 19 transplant subspecialists) to explore the acceptability of an immunization app to be used in the pretransplant period. Based on these findings, CANImmunize Inc developed the Immunize PediatricTransplant app. We next held 2 focus group discussions with 5-6 transplant stakeholders/group (n=11; 5 parents of transplant recipients, 2 primary care physicians, 2 transplant nurse coordinators, and 2 transplant subspecialists) to receive feedback on the app. After the app modifications were made, alpha testing was conducted on the functional prototype. We then implemented beta testing with 12 stakeholders (6 parents of transplant recipients, 2 primary care doctors, 2 transplant nurse coordinators, and 2 transplant subspecialists) to refine the app through an iterative process. Finally, the stakeholders completed the user version of the Mobile Application Rating Scale (uMARS) to assess the functionality and quality of the app.

RESULTS

A new Android- and Apple-compatible app, Immunize PediatricTransplant, was developed to improve immunization delivery in the pretransplant period. The app contains information about vaccine use in the pretransplant period, houses a complete immunization record for each child, includes a communication tool for parents and care providers, and sends automated reminders to parents and care providers when immunizations are due. During usability testing, the stakeholders were able to enter a mock vaccine record containing 16 vaccines in an average of 8.1 minutes (SD 1.8) with 87% accuracy. The stakeholders rated engagement, functionality, aesthetics, and information quality of the app as 4.2/5, 4.5/5, 4.6/5, and 4.8/5, respectively. All participants reported that they would recommend this app to families and care teams with a child awaiting solid organ transplant.

CONCLUSIONS

Through a systematic, user-centered, agile, iterative approach, the Immunize PediatricTransplant app was developed to improve immunization delivery in the pretransplant period. The app tested well with end users. Further testing and agile development among patients awaiting transplant are needed to understand real-world acceptability and effectiveness in improving immunization rates in children awaiting transplant.

摘要

背景

疫苗可预防感染在儿科移植受者中会导致严重的发病率、死亡率和成本。然而,在移植时,不到20%的儿童完成了可预防这些疾病的适龄免疫接种。智能手机应用程序有潜力通过提供疫苗教育、发送疫苗提醒以及促进家长与多学科医疗团队之间的沟通来提高免疫接种率。

目的

本研究的目的是描述一款智能手机应用程序“Immunize PediatricTransplant”的开发过程,以促进移植前免疫接种,并报告该应用程序应用于目标人群时的功能和可用性。

方法

我们采用了以移动健康敏捷开发与评估生命周期为指导的混合方法研究设计。我们首先完成了一项形成性研究,包括对移植利益相关者进行半结构化访谈(12名初级保健医生、40名移植受者的父母或监护人、11名移植护士协调员和19名移植专科医生),以探讨在移植前阶段使用免疫接种应用程序的可接受性。基于这些发现,CANImmunize公司开发了“Immunize PediatricTransplant”应用程序。接下来,我们与每组5 - 6名移植利益相关者(共11人;5名移植受者的父母、2名初级保健医生、2名移植护士协调员和2名移植专科医生)进行了2次焦点小组讨论,以获取对该应用程序的反馈。在对应用程序进行修改后,对功能原型进行了alpha测试。然后,我们对12名利益相关者(6名移植受者的父母、2名初级保健医生、2名移植护士协调员和2名移植专科医生)进行了beta测试,通过迭代过程对应用程序进行完善。最后,利益相关者完成了移动应用程序评分量表(uMARS)的用户版,以评估该应用程序的功能和质量。

结果

开发了一款新的兼容安卓和苹果系统的应用程序“Immunize PediatricTransplant”,以改善移植前阶段的免疫接种服务。该应用程序包含移植前阶段疫苗使用的信息,为每个儿童建立完整的免疫接种记录,包括家长和护理人员的沟通工具,并在免疫接种到期时向家长和护理人员发送自动提醒。在可用性测试中,利益相关者平均用时8.1分钟(标准差1.8)输入包含16种疫苗的模拟疫苗记录,准确率为87%。利益相关者对该应用程序的参与度、功能、美观度和信息质量的评分分别为4.2/5、4.5/5、4.6/5和4.8/5。所有参与者均表示会向有儿童等待实体器官移植的家庭和护理团队推荐这款应用程序。

结论

通过系统的、以用户为中心的、敏捷的、迭代的方法,开发了“Immunize PediatricTransplant”应用程序,以改善移植前阶段的免疫接种服务。该应用程序在终端用户中测试效果良好。需要对等待移植的患者进行进一步测试和敏捷开发,以了解其在提高等待移植儿童免疫接种率方面的实际可接受性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae28/8796049/5ac78df4a3e2/formative_v6i1e32273_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验